6.4(top 5%)
impact factor
25.2K(top 1%)
1.0M(top 1%)
280(top 1%)
6.8(top 5%)
extended IF
all documents
doc citations
412(top 1%)

Top Articles

1Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology20103,150
2Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?British Journal of Pharmacology20041,839
3Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivoBritish Journal of Pharmacology19901,734
4Principles of early drug discoveryBritish Journal of Pharmacology20111,689
5The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology20081,463
6Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology20101,415
7Stimulus‐secretion coupling: the concept and clues from chromaffin and other cellsBritish Journal of Pharmacology19681,327
8Microglial M1/M2 polarization and metabolic statesBritish Journal of Pharmacology20161,308
9The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology20071,287
10The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartateBritish Journal of Pharmacology19831,263
11Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJPBritish Journal of Pharmacology20151,213
12Therapeutic antibodies: successes, limitations and hopes for the futureBritish Journal of Pharmacology20091,123
13Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewersBritish Journal of Pharmacology20181,122
14Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effectsBritish Journal of Pharmacology20111,102
15Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)British Journal of Pharmacology20111,082
16The role of inflammation in CNS injury and diseaseBritish Journal of Pharmacology20061,060
17The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxideBritish Journal of Pharmacology19871,024
18Experimental design and analysis and their reporting: new guidance for publication in BJPBritish Journal of Pharmacology2015981
19Endothelial dysfunction in diabetesBritish Journal of Pharmacology2000966
20Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideBritish Journal of Pharmacology2001945
22The use of animal models in diabetes researchBritish Journal of Pharmacology2012932
23Rapid method for the determination of 5‐hydroxytryptamine and 5‐hydroxyindoleacetic acid in small regions of rat brainBritish Journal of Pharmacology1970922
24Guide to Receptors and Channels (GRAC), 5th editionBritish Journal of Pharmacology2011827
25A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxationBritish Journal of Pharmacology1989811
26Binding, gating, affinity and efficacy: The interpretation of structure-activity relationships for agonists and of the effects of mutating receptorsBritish Journal of Pharmacology1998808
27Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeuticsBritish Journal of Pharmacology2009783
28Impact of OATP transporters on pharmacokineticsBritish Journal of Pharmacology2009783
29Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in plateletsBritish Journal of Pharmacology1987748
30Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptorBritish Journal of Pharmacology2015739
31l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitroBritish Journal of Pharmacology1990723
32Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseasesBritish Journal of Pharmacology2017722
33Endothelium‐dependent hyperpolarization of canine coronary smooth muscleBritish Journal of Pharmacology1988718
34Role of Transmitter Uptake Mechanisms in Synaptic NeurotransmissionBritish Journal of Pharmacology1971717
35Minocycline: far beyond an antibioticBritish Journal of Pharmacology2013717
36The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesiaBritish Journal of Pharmacology1992709
37Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymesBritish Journal of Pharmacology2011700
38The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)British Journal of Pharmacology2000698
39CAN SOCIAL INTERACTION BE USED TO MEASURE ANXIETY?British Journal of Pharmacology1978692
40Acetylcholine beyond neurons: the non‐neuronal cholinergic system in humansBritish Journal of Pharmacology2008689
41The discovery of nitric oxide and its role in vascular biologyBritish Journal of Pharmacology2006682
42The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea‐pig ileum longitudinal muscle stripBritish Journal of Pharmacology1969674
43Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerolBritish Journal of Pharmacology2002674
44How corticosteroids control inflammation: Quintiles Prize Lecture 2005British Journal of Pharmacology2006650
45Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteriaBritish Journal of Pharmacology2008647
46Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non‐adrenergic inhibitory nerves in the gutBritish Journal of Pharmacology1970644
47Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studiesBritish Journal of Pharmacology1991630
48OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamiliesBritish Journal of Pharmacology2012627
49Acetylcholine releases endothelium‐derived hyperpolarizing factor and EDRF from rat blood vesselsBritish Journal of Pharmacology1988626
50Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studiesBritish Journal of Pharmacology1991624